UK Teva Ruling Brings Patent Remedy Into Question
An attack on a patent and divisional applications on the basis of an Arrow declaration application — the name stemming from the case of Arrow Generics & Anor v. Merck in 2007 —...To view the full article, register now.
Already a subscriber? Click here to view full article